The international clinical phase 2b trials for ABX203, also known as NasVac, HeberNasVac, were abondoned because ABX203 was unlikely to achieve the trials' endpoints. This was in sharp contrast to the results obtained in a clinical trial conducted in Bangladesh. So far HeberNasVac is approved in Cuba(its original place of invention of this therapeutic vaccine), and we have heard very little about its effectiveness out of Cuba. So becareful and don't believe the hype from the local press.
Well if it comes that will a be golden ray for hbvers. Any more idea about it in BD.
Hello. As far as I know from Bangladeshi news Nasvac will come soon. A pharmacy company applied to get approved from gov to make this medicine available .